ANDA 77985, held by Pharmazone. Zolpidem Tartrate.
As of Nov 16, 2026, ANDA 77985 (Zolpidem Tartrate), held by Pharmazone, was first approved by FDA on Apr 23, 2007, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 23, 2007 | Original application | Approved |
| Zolpidem Tartrate5MG · tablet;oral | Zolpidem Tartrate | Discontinued |
| Zolpidem Tartrate10MG · tablet;oral | Zolpidem Tartrate | Discontinued |
| Mar 20, 2013 | Supplement 5Labeling | Approved | None posted |
| May 4, 2009 | Supplement 3Labeling | Approved | None posted |
| Oct 7, 2008 | Supplement 2Labeling | Approved | None posted |
| Dec 31, 2007 | Supplement 1Labeling | Approved | None posted |
| Apr 23, 2007 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters